Man (27) settles case over alleged failure to inform mother of epilepsy drug risks for €5m

A 27-year-old man has settled a High Court case for €5 million against Tallaght University Hospital and the HSE. The lawsuit alleged that his mother was not properly informed of the risks of taking the epilepsy drug Epilim during pregnancy.
Why it matters
The case highlights the legal and medical implications of failing to disclose potential side effects of medication to pregnant patients.
A 27-year-old man with spina bifida who sued claiming there was an alleged failure to inform his mother when she was pregnant of a risk associated with taking an epilepsy drug has settled a High Court action for €5 million.
It was claimed there was a failure to inform Mark Kavanagh’s mother Collette that sodium valproate − with the brand name Epilim − carried an estimated 1 per cent risk of spina bifida for a foetus.
The settlement of Kavanagh’s case against Tallaght University Hospital (TUH) and the HSE is without an admission of liability and was reached after mediation.
Oonah McCrann, Kavanagh’s counsel instructed by Cantillons Solicitors, told the court his client’s mother was diagnosed with epilepsy in the early 1990s, and before and during her pregnancy she was prescribed Epilim.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in